Resistance of dialyzed patients to erythropoietin
- PMID: 26041422
- PMCID: PMC4459468
- DOI: 10.1016/j.bjhh.2015.02.001
Resistance of dialyzed patients to erythropoietin
Abstract
Resistance to recombinant human erythropoietin is a common condition in dialyzed patients with chronic kidney disease and is associated with more hospitalizations, increased mortality and frequent blood transfusions. The main cause of hyporesponsiveness to recombinant human erythropoietin in these patients is iron deficiency. However, a high proportion of patients does not respond to treatment, even to the use of intravenous iron, which indicates the presence of other important causes of resistance. In addition to the iron deficiency, the most common causes of resistance include inflammation, infection, malnutrition, inadequate dialysis, and hyperparathyroidism, although other factors may be associated. In the presence of adequate iron stores, other causes should be investigated and treated appropriately.
Keywords: Dialysis; Erythropoietin; Iron.
Copyright © 2015 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. All rights reserved.
References
-
- Romão Junior J.E. A doença renal crônica: do diagnóstico ao tratamento. Prática Hospitalar. 2007;52:183–187.
-
- Manual de Transplante Renal. Associação Brasileira de Transplantes de Órgãos (ABTO). Available from: http://www.abto.org.br/abtov03/Upload/file/Profissional_Manual/manual_tr... [cited 31.10.14].
-
- Censo da Sociedade Brasileira de Nefrologia 2013. São Paulo: Sociedade Brasileira de Nefrologia (SBN). Available from: http://www.sbn.org.br/pdf/censo_2013-14-05.pdf [cited 31.10.14].
-
- Kazmi W.H., Kausz A.T., Khan S., Abichandani R., Ruthazer R., Obrador G.T. Anemia: an early complication of chronic renal insufficiency. Am J Kidney Dis. 2001;38(4):803–812. - PubMed
-
- National Kidney Foundation K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006;26(Suppl. 3):1–145. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
